GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » FCF Margin %

Medical Developments International (ASX:MVP) FCF Margin % : -6.28% (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medical Developments International FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medical Developments International's Free Cash Flow for the six months ended in Dec. 2024 was A$-1.26 Mil. Medical Developments International's Revenue for the six months ended in Dec. 2024 was A$19.99 Mil. Therefore, Medical Developments International's FCF Margin % for the quarter that ended in Dec. 2024 was -6.28%.

As of today, Medical Developments International's current FCF Yield % is -13.53%.

The historical rank and industry rank for Medical Developments International's FCF Margin % or its related term are showing as below:

ASX:MVP' s FCF Margin % Range Over the Past 10 Years
Min: -76.87   Med: -40.41   Max: 55.12
Current: -18.23


During the past 13 years, the highest FCF Margin % of Medical Developments International was 55.12%. The lowest was -76.87%. And the median was -40.41%.

ASX:MVP's FCF Margin % is ranked worse than
78.76% of 970 companies
in the Drug Manufacturers industry
Industry Median: 0.89 vs ASX:MVP: -18.23


Medical Developments International FCF Margin % Historical Data

The historical data trend for Medical Developments International's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International FCF Margin % Chart

Medical Developments International Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -38.74 -61.13 -71.49 -76.87 -42.08

Medical Developments International Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -84.80 -70.81 -54.81 -31.45 -6.28

Competitive Comparison of Medical Developments International's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Developments International's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Medical Developments International's FCF Margin % falls into.


;
;

Medical Developments International FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Medical Developments International's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=-13.949/33.149
=-42.08 %

Medical Developments International's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-1.255/19.987
=-6.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Developments International FCF Margin % Related Terms

Thank you for viewing the detailed overview of Medical Developments International's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medical Developments International Business Description

Traded in Other Exchanges
Address
4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International Headlines

From GuruFocus

Roundhill Announces Two Fund Closures

By PRNewswire PRNewswire 03-18-2022